Artificial Intelligence (AI) revolutionizing healthcare: A look at the present and future!
Artificial Intelligence (AI) revolutionizing healthcare: A look at the present and future!

Artificial Intelligence (AI) revolutionizing healthcare: A look at the present and future!

Artificial intelligence (AI) is revolutionizing healthcare, offering unprecedented opportunities to enhance diagnostics, treatments, and patient engagement

Kiran Shroff Article rating: 4.1

From machine learning to robotic surgery, AI technologies are reshaping the medical landscape, promising improved outcomes, reduced costs, and more personalized care.

Market Wrap: Benchmark indices close lower while Broader indices underperform!
Market Wrap: Benchmark indices close lower while Broader indices underperform!

Market Wrap: Benchmark indices close lower while Broader indices underperform!

On Monday, Benchmark indices concluded the trading day on a negative note as Sensex substantially declined by 1.14 per cent and closed at 73,399.78 level, while Nifty also plunged by 1.1 per cent and closed at 22,272.50 level.

Siddharth Mane Article rating: 3.7

On April 12, 2024, foreign institutional investors (FII) offloaded shares worth Rs 8,027 crore, while domestic institutional investors (DII) bought shares worth Rs 6,341.53 crore.

175 per cent from its 52-week low of Rs 77.56: Promoter bought 4,31,230 shares or 0.12 per cent stake; Company into significant move towards growth by raising Rs 543 crore!
175 per cent from its 52-week low of Rs 77.56: Promoter bought 4,31,230 shares or 0.12 per cent stake; Company into significant move towards growth by raising Rs 543 crore!

175 per cent from its 52-week low of Rs 77.56: Promoter bought 4,31,230 shares or 0.12 per cent stake; Company into significant move towards growth by raising Rs 543 crore!

The promoter of the company bought 4,31,230 shares or 0.12 per cent stake in the company and increased their total stake in the company to 67.31 per cent as of March 18, 2024.

Kiran Shroff Article rating: 4.0

While the industry has an average PE ratio of 37.2x, this company's shares trade at a discount of 25.2x, all while boasting a return on equity (ROE) of 26.4 per cent and a return on capital employed (ROCE) of 32 per cent.

High ROE & high ROCE multibagger civil construction stock; Board announces fundraising worth Rs 486,00,00,000 to accelerate growth!
High ROE & high ROCE multibagger civil construction stock; Board announces fundraising worth Rs 486,00,00,000 to accelerate growth!

High ROE & high ROCE multibagger civil construction stock; Board announces fundraising worth Rs 486,00,00,000 to accelerate growth!

The stock gave multibagger returns of 300 per cent in just 1 year, 11,100 per cent in 3 years and a whopping 29,700 per cent in 5 years.

Kiran Shroff Article rating: 4.0

The shares of the company have a PE of 12x whereas the sectoral PE is 19x with an ROE of 85.9 per cent & an ROCE of 83.8 per cent.

Market Wrap: Benchmark indices plummet while Nifty Pharma plunges over 1.5 per cent!
Market Wrap: Benchmark indices plummet while Nifty Pharma plunges over 1.5 per cent!

Market Wrap: Benchmark indices plummet while Nifty Pharma plunges over 1.5 per cent!

On Friday, Benchmark indices concluded the trading day on a negative note as Sensex substantially declined by 1.06 per cent and closed at 74,244.90 level, while Nifty also plunged by 1.03 per cent and closed at 22,519.40 level.

Siddharth Mane Article rating: 3.3

On April 10, 2024, foreign institutional investors (FII) bought shares worth Rs 2,778.17 crore, while domestic institutional investors (DII) bought shares worth Rs 163.36 crore.

This small-cap estate developer resolves legal issue with OLV & OLPS society, unlocks Rs 350 crores GDV potential and Rs 225 crore GDV for redevelopment
This small-cap estate developer resolves legal issue with OLV & OLPS society, unlocks Rs 350 crores GDV potential and Rs 225 crore GDV for redevelopment

This small-cap estate developer resolves legal issue with OLV & OLPS society, unlocks Rs 350 crores GDV potential and Rs 225 crore GDV for redevelopment

The shares of company trading at Rs 347 with a market cap of Rs 1,535.12 crore. The stock price has given 16 per cent returns in the last month.

Prajwal Wakhare Article rating: 3.7

Since incorporation, the company have completed 42 projects with a developed area of more than 1,046,543.20 square feet in the South-Central Mumbai region. In addition to the completed Projects, the company has 13 ongoing projects with a developable area of 2,034,434.40 square feet and saleable RERA carpet area 6,09,928 square feet and 16 upcoming Projects with an estimated carpet area of 744,149 square feet.

RSS
First166167168169171173174175Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR